University of California San DiegoDisclosures
Dr. Bailey receives or has received speaking honoraria from Amylin, Novo Nordisk, BD, Sanofi-Aventis; and receives or has received research support from Animas, Amylin, Bayer, BD, Biodel, Boehringer Ingelheim, Corcept, CPEX, Bristol Myers Squibb, Dexcom, Gilead, GlasoSmithKlein, Halozyme, Incyte, Lifescan, Lilly, Medtronic, Merck, Novo Nordisk, Resmed, Roche, Sanofi Aventis, Xoma.
|Program Name||Last Air Date||Hosts/Guests|
|The Regulatory Environment for the Artificial Pancreas||10/31/2018|
|Shaping Diabetes Management With Digital Technology and Genomics||05/02/2016|
|New Experimental Treatments for Diabetic Wounds||06/08/2016|
|Structured Self-Monitoring of Blood Glucose||03/17/2016|
|Advances in Continuous Glucose Monitoring||04/23/2010|
You need to be logged in to save this episode to a playlist.